The effect of the response to the coronavirus dis-ease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma
- Authors
- Kang, Ka-Won; Lee, Byung-Hyun; Jeon, Min Ji; Yu, Eun Sang; Kim, Dae Sik; Lee, Se Ryeon; Sung, Hwa Jung; Choi, Chul Won; Park, Yong; Kim, Byung Soo
- Issue Date
- 11월-2021
- Publisher
- KOREAN ASSOC INTERNAL MEDICINE
- Keywords
- Treatment outcome; Lymphoma; Multiple myeloma; Coronavirus
- Citation
- KOREAN JOURNAL OF INTERNAL MEDICINE, v.36, no.6, pp.1459 - +
- Indexed
- SCIE
KCI
- Journal Title
- KOREAN JOURNAL OF INTERNAL MEDICINE
- Volume
- 36
- Number
- 6
- Start Page
- 1459
- End Page
- +
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/135827
- DOI
- 10.3904/kjim.2021.186
- ISSN
- 1226-3303
- Abstract
- Background/Aims:Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. We aimed to determine the effect of COVID-19 countermeasures on treatment out-comes in this patient population. Methods: We retrospectively analyzed data on patients treated for lymphoma or multiple myeloma in two tertiary hospitals in Seoul. Patients were divided into two groups: group 1 included patients who received chemotherapy between Sep-tember and December 2019 (the control period), and group 2 included patients who received chemotherapy between September and December 2020 (the study period). Countermeasures to COVID-19 were applied to the patients in group 2. The countermeasures implemented included mask wearing and regular hand-washing at home and in hospital; COVID-19 risk assessments on all hospital visi-tors; and pre-emptive COVID-19 screening for all newly hospitalized patients and their resident guardians. Results: No differences in treatment outcomes, including treatment response, incidence and duration of neutropenia or neutropenic fever, delays in chemo-therapy, or number of deaths during chemotherapy, were observed between the g roups. None of the patients in group 2 tested positive for COVID-19, and there were no COVID-19-related deaths during the study period. Conclusions: Countermeasures to COVID-19 did not affect treatment outcomes in patients receiving chemotherapy for lymphoma or multiple myeloma. Data on the effect of countermeasures to COVID-19 on treatment outcomes should continue to be analyzed to ensure that treatment outcomes are not adversely affected.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.